Key result
Transarterial NBCA embolization for post-EVAR type 2 endoleak linked to conservatively managed ischemic colitis.
Case Report (n=1)
No
Transarterial embolization for type 2 endoleak post-EVAR can be complicated by ischemic colitis, which may be successfully managed with conservative treatment.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to ischemic colitis risk with embolization for type 2 endoleak; single case leaves open incidence and management questions.
A 71 year old man was diagnosed to have enlargement of abdominal aortic aneurysm due to type 2 endoleak two years after endovascular aneurysm repair (EVAR). 3D-CT demonstrated a type 2 endoleak that originated from the superior mesenteric artery that fed the inferior mesenteric artery and the right iliolumbar artery that flowed into the 4th lumbar artery. Transarterial embolization was performed by means of N-butyl-2-cyanoacrylate (NBCA). After the treatment, he suffered ischemic colitis that extended from the sigmoid colon to the descending colon. Conservative treatment was mainly performed, and clinical improvement was observed over time. He was discharged after 73 postoperative days.
No takes yet. Share an insight, caveat, or question.
Ito et al. (2012) conducted a case report in Type 2 endoleak after EVAR (n=1). Transarterial embolization with N-butyl-2-cyanoacrylate (NBCA) was evaluated on Development of ischemic colitis. Transarterial embolization with N-butyl-2-cyanoacrylate for a type 2 endoleak after EVAR resulted in ischemic colitis, which was successfully managed with conservative treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: